Live intraday price
Compare with our price levels
Close 2026-09-30: $15.26 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)
Not in the buy zone yet — needs to drop 11.7% · 1 whale recently bought
🎯 Trade plan by price level
Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks
Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated
Risk : reward 1 : 2.5Moves ~$0.94 a day
⚖️ Positives and risks
- ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
- ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 27.00 (upside +77%, 5 ราย)
- ●รายได้หดตัว -38% เทียบปีก่อน
🕯️ Price chart
Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold
🐋 Whales holding this stock
From each whale's latest quarterly filing
👔 Insider buying & selling
Latest trades from SEC Form 4 filings
ARNOLD FRANCES · Director
2026-09-01 · 1,000 shares @ $16.00 · pre-planned sale (10b5-1)
Nally Michael · CEO · Director
2026-03-04 · 20,000 shares @ $12.00
AFEYAN NOUBAR / Flagship VentureLabs VI LLC / Flagship Pioneering Fund VI, L.P. / Flagship Pioneering Fund VII, L.P. / Nutritional Health LTP Fund, L.P. / Flagship Pioneering Special Opportunities Fun · Director · 10%+ owner
2026-03-02 · 1,562,500 shares @ $16.00
AFEYAN NOUBAR / Flagship Pioneering, LLC / Flagship VentureLabs VI Manager LLC / Flagship Pioneering Fund VI General Partner LLC / Flagship Pioneering Fund VII General Partner LLC / Nutritional Health · Director · 10%+ owner
2026-03-02 · 1,562,500 shares @ $16.00
Mendillo Jane L · Director
2026-03-02 · 1,500 shares @ $16.00
Silvers Jason · CFO
2026-03-02 · 1,000 shares @ $16.00
Silvers Jason · CFO
2026-03-02 · 500 shares @ $16.00
Grous Beth · Officer
2026-03-02 · 300 shares @ $16.00
📊 Past earnings and price reaction
Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days
Actual EPS -$0.52 · est. -$0.49 · Before open
Day 1
Next 20 days
Actual EPS -$1.07 · est. -$0.51 · Before open
Day 1
Next 20 days
Listen to the earnings call or read the full report on GENB's investor relations page ↗ · Earnings data from Yahoo Finance
💬 User reviews
Rate and review this stock (sign-in required) — reviews don't affect the system's scores
Loading…
Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person
📰 Latest news
AI Could Eventually Crack Cancer and Drug Discovery, Says Arm CEO — But This Is What’s Holding It Back
Benzinga · 2026-09-08
How Nvidia’s Investment Juggernaut Can Jump from Big to Enormous
Barrons.com · 2026-09-07
Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines
BioPharma Dive · 2026-08-28
EXCLUSIVE: Nvidia GPUs Are Essential—But They Won't Decide Who Wins AI Drug Discovery, Generate CTO Says
Benzinga · 2026-08-27
Cathie Wood Sends a $20 Million Signal on Broadcom Stock
GuruFocus.com · 2026-08-27
🔬 Deep dive
For those who want the detailed numbers